Do positive microbial antibodies and a negative blood PCR mean different things?

The claim is substantially supported: microbial serology and blood PCR answer different biological questions and must be interpreted in relation to timing, treatment, assay design, and the suspected site of disease.

Serology and infection status

• Positive microbial antibodies—especially IgG—often indicate prior exposure rather than current infection. In anaplasmosis, IgG can remain elevated for months and occasionally up to 4 years after illness.
• Persistent antigenic stimulation is a biologically plausible cause of ongoing antibody positivity, but a single positive antibody result cannot distinguish this from resolved infection, active infection, or cross-reactivity.
• For Anaplasma phagocytophilum, CDC favors paired acute/convalescent IgG IFA testing; a fourfold titer rise supports recent infection. Isolated IgM is not a reliable marker of recency.
• Anaplasma and Ehrlichia antibodies can cross-react, and commercial assays may not reliably differentiate the species.

Blood PCR: what a negative result means

• A negative blood PCR meaningfully lowers evidence for infection actively circulating in that blood specimen at that time. For acute anaplasmosis, estimated whole-blood PCR sensitivity is 70–100% in week 1, 50–100% in week 2, and <50% later.
• Its negative value declines after treatment: PCR sensitivity may decrease within 48 hours of appropriate antibiotics. Low or temporally variable blood pathogen burden can also fall below assay detection thresholds.

Compartmentalized and variable infection

• A negative blood PCR does not exclude infection concentrated outside blood. In culture-negative endocarditis, Bartonella or Coxiella burnetii may be identified by PCR of excised valve tissue despite unrevealing blood testing.
• Similarly, CSF or other disease-site specimens may be more informative when the syndrome localizes to that compartment.

Bottom line

• Positive antibodies support immune recognition or prior exposure, not proof of active circulating infection; negative blood PCR reduces—but cannot by itself rule out—localized, low-level, intermittent, late-stage, or post-treatment infection.